Facebook Pixel
Pluto Money Logo
Pluto Money Logo
Suven Life Sciences Limited

Suven Life Sciences Limited (SUVEN)

246.5

INR
+5.81(+2.41%)
As of June 30, 2025 9:48:00 AM

About Suven Life Sciences Limited

Suven Life Sciences Ltd. is a biopharmaceutical company that focuses on discovering, developing, and commercializing new chemical entities (NCEs) for the treatment of severe central nervous system (CNS) disorders. Specializing in areas such as Alzheimer's, schizophrenia, depression, and cognitive disorders, Suven Life Sciences is dedicated to advancing medical science with innovative therapeutic solutions. Headquartered in Hyderabad, India, the company operates internationally, supplying intermediates and active pharmaceutical ingredients (APIs) to major global pharmaceutical players. Suven's research-driven approach positions it as a significant contributor to the pharmaceutical industry, particularly in the segment of CNS therapies where there is high demand for breakthroughs. By facilitating drug discovery collaborations and maintaining a strong R&D pipeline, Suven Life Sciences continues to play a crucial role in addressing unmet medical needs and advancing healthcare globally.

RevenueLast 12 months
NA
+NA YoY
EBITDALast 12 months
NA
Price to Sales RatioTTM
693.01
Operating MarginLast 12 months
-3078.90
+-38.49572362904578% quarterly YoY
Market Cap
5248.82 CrINR
Employees
141
CEO
Mr. Venkateswarlu Jasti M.Pharm. M.S.
Website
©2025 Pluto Money All Rights Reserved.